Lenvatinib Mesylate and Ocrelizumab Intravenous
Determining the interaction of Lenvatinib Mesylate and Ocrelizumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lenvatinib
Brand name: Lenvima, Lenvima 8 mg daily-dose, Lenvima 20 mg daily-dose, Lenvima 12 mg daily-dose
Synonyms: Lenvatinib
Generic Name: ocrelizumab
Brand name: Ocrevus
Synonyms: Ocrelizumab (Intravenous), Ocrelizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lenvatinib Mesylate-Ocrevus
- Lenvatinib Mesylate-Octagam
- Lenvatinib Mesylate-Octagam Gammagard S/D
- Lenvatinib Mesylate-Octocaine
- Lenvatinib Mesylate-Octocaine 100
- Lenvatinib Mesylate-OctreoScan
- Ocrelizumab Intravenous-Lenvima
- Ocrelizumab Intravenous-Lenvima (14 MG Daily Dose)
- Ocrelizumab Intravenous-Lenvima (18 MG Daily Dose)
- Ocrelizumab Intravenous-Lenvima (20 MG Daily Dose)
- Ocrelizumab Intravenous-Lenvima (24 MG Daily Dose)
- Ocrelizumab Intravenous-Lenvima (8 MG Daily Dose)